Enzon Pharmaceuticals Inc. (ENZN)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▲ | |
| Q2 2016 | |||||
| ≡ | Carl Icahn - Icahn Capital Management | Sell 100.00% | 5,904,863 | 0.01 | |
| Q1 2014 | |||||
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 4,337,858 | 0.15 | |
| Q4 2013 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 43.60% | 3,353,595 | 0.12 | |
| Q1 2013 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 2.02% | 158,915 | 0.02 | |
| Q4 2012 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 12.78% | 1,150,510 | 0.17 | |
| Q1 2011 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 0.71% | 64,300 | 0.04 | |
| Q4 2010 | |||||
| ≡ | Seth Klarman - Baupost Group | Reduce 12.69% | 1,317,520 | 0.95 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.